Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Current Health—purchased by Best Buy for $400 million in 2021—is set to become an independent company again, with co-founder Christopher McGhee taking over. The electronics retailer appears to be backing away from remote patient monitoring services, shifting its healthcare division's focus to consumer products that improve the lives of seniors.
The U.S. is one of 23 countries that consider workforce AI training and education only a medium priority. Indeed, our homeland has a less detailed plan than 13 other nations.
The legal case brought by all 50 states, Washington D.C., and multiple U.S. territories against Purdue Pharma and the Sackler family has come to an end, with settlement funds set to be used for addiction recovery.
A class-action lawsuit claims CVS Health sent text messages to customers and patients, inciting fear over a PBM regulation up for vote in Louisiana. Plaintiffs allege the incident violates state data privacy and political communication laws.
A “sophisticated cybercrime group” is being blamed for an attack on the network of the private insurer, which may have exposed social security numbers and protected health information. The incident is still being investigated.
AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.
Researchers have developed a novel cardiovascular MRI protocol as an option to the invasive gold standard, endomyocardial biopsy, for monitoring heart-transplant patients at risk of suffering organ rejection.
A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.
The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.
Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.